Back to search results

A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus

Abroad (travel likely)RecruitingPHASE2

Conditions

MASH - Metabolic Dysfunction-Associated Steatohepatitis · T2DM (Type 2 Diabetes Mellitus)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Ditan Hospital of integrated traditional Chinese and Western Medicine Center, Beijing, Beijing Municipality, China

  • Southwest Hospital of Third Military Medical University, Chongqing, Chongqing Municipality, China

  • The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China

  • The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

  • Southern Hospital, Guangzhou, Guangdong, China

  • Wuhan Union Hospital of Huazhong University of Science and Technology, Wuhan, Hebei, China

  • Taihe Hospital, Shiyan, Hubei, China

  • Xiangya hospital of Central South University, Changsha, Hunan, China

  • The First Affiliated Hospital of Jilin University, Changchun, Jilin, China

  • Renji hospital of Shanghai Jiao Tong University School of Medical, Shanghai, Shanghai Municipality, China

  • Ruijin Hospital of Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai Municipality, China

  • Shanghai Public Health Clinical Center, Shanghai, Shanghai Municipality, China

  • Shanghai Punan Hospital of Pudong New District (Punan Branch of Renji Hospital, Shanghai Jiaotong University School of Medicine), Shanghai, Shanghai Municipality, China

  • The First Affiliated Hospital of Xi'an Jiao Tong University, Xi’an, Shanxi, China

  • Tianjin Second People's Hospital, Tianjin, Tianjin Municipality, China

  • The First Teaching Hospital of Xinjiang Medical University, Ürümqi, Xinjiang, China

  • The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China

Study leads

  • Hai Li, professor

    Principal Investigator

    Shanghai Punan Hospital of Pudong New District (Punan Branch of Renji Hospital, Shanghai Jiaotong University School of Medicine)

View source on ClinicalTrials.gov(opens in a new tab)